Axsome Therapeutics (NASDAQ:AXSM) Stock Price Expected to Rise, Morgan Stanley Analyst Says

Axsome Therapeutics (NASDAQ:AXSM – Free Report) had its target price boosted by Morgan Stanley from $125.00 to $190.00 in a report released on Thursday,Benzinga reports. Morgan Stanley currently has an overweight rating on the stock. Several other equities analysts have also recently commented on AXSM. Truist Financial raised their price target on shares of Axsome […]

Mar 2, 2025 - 08:45

Axsome Therapeutics (NASDAQ:AXSM – Free Report) had its target price boosted by Morgan Stanley from $125.00 to $190.00 in a report released on Thursday,Benzinga reports. Morgan Stanley currently has an overweight rating on the stock. Several other equities analysts have also recently commented on AXSM. Truist Financial raised their price target on shares of Axsome […]